Cancer chemotherapy resistance (MDR) is the innate and/or acquired ability of cancer cells
to evade the effects of chemotherapeutics and is one of the most pressing major dilemmas in …

… the biophysical properties of the cellular membrane (Rauch and Pluen, 2007) and that,
these membrane alterations can be brought about by a change in cytosolic pH (Rauch, 2009b). …

… TRAIL is a type II membrane protein, whose C-terminal extracellular domain shows clear
homology to other TNF family members. TRAIL transcripts are detected in a variety of human …

In recent years an increasing number of publications have emphasized the growing
importance of hydrogen ion dynamics in modern cancer research, from etiopathogenesis and …

… I = I, „c”/(c" -- K",), where I is the current, I, is the maximal current, c is the cAMP concentration,
… 13) and c = 15 pM as the concentration of cAMP estimated to produce 90% of the maximal …

The ectodomains of numerous proteins are released from cells by proteolysis to yield
soluble intercellular regulators. The responsible protease, tumor necrosis factor-α converting …

… ligand family member) express the C–terminal ~150 amino acids, … c), which were
morphologically compatible with apoptotic necrosis (d, arrow). Scale bar represents 50 μm in a and c …

… Bone marrow of either female BALB/c or C57BLU6 mice was depleted of T cells with
monoclonal antibody (mAb) J1j (anti-Thy-1), mAb C3P0 (anti-CD2), mAb RL172 (anti-CD4), and …

… ‐dimensional SDS–PAGE (B and C). Boxes 1 and 2 in (C) indicate the gel regions cut out …
4 min at 96C; 33 cycles, 1 min at 96C, 1 min at 46C, 2 min at 72C; and one cycle, 5 min at 72…

We have previously reported the identification of a novel mast cell growth factor (MGF) that
was shown to be a ligand for c-kit and is encoded by a gene that maps near the steel locus on …